Arkolith/Insider Trading/CEMI/Form 4

Davis Katherine Lyon

DirectorCHEMBIO DIAGNOSTICS, INC. (CEMI) · full profile →Form 4 · filed May 1, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 26, 2023Tender(U)106K$0.45$48K0
Jun 24, 2021Option exercise(M)16K——106K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2023Disposed to issuer(D)41K——0
Apr 27, 2023Disposed to issuer(D)36K——0
Apr 27, 2023Disposed to issuer(D)32K——0
Jun 24, 2021Option exercise(M)16K—$00

Transaction Codes

U
See SEC Form 4 code table
M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-022230) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML